Stock MLTX MOONLAKE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq
Other stock markets
 01:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
39.49 USD -1.69% Intraday chart for MoonLake Immunotherapeutics -8.80% -34.61%
10/06 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis CI
07/05 MoonLake Immunotherapeutics Q1 Net Loss Widens MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOONLAKE IMMUNOTHERAPEUTICS Stock MoonLake Immunotherapeutics
 2.48B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.57B -
BIONTECH SE Stock BioNTech SE
 20.82B -
GENMAB A/S Stock Genmab A/S
 16.19B
  1. Stock Market
  2. Equities
  3. MLTX Stock
  4. Charts MoonLake Immunotherapeutics
  5. Sector Chart